Not yet recruitingPhase 3NCT07228104
Use of Steroid Injections to Prevent the Recurrence of Tracheal Stenosis in Idiopathic Subglottic Stenosis
Studying Idiopathic subglottic stenosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Alexander Hillel, MD, MDJohns Hopkins University
- Intervention
- Triamcinolone 0.1%(drug)
- Enrollment
- 226 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2026 – 2032
Study locations (1)
- Johns Hopkins Hospital, Baltimore, Maryland, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07228104 on ClinicalTrials.govOther trials for Idiopathic subglottic stenosis
Additional recruiting or active studies for the same condition.